The Judicial Panel on MultiDistrict Litigation (JPML) today approved MDL-2100, In Re: Yasmin and YAZ (Drospirenone) Marketing, Sales Practices and Products Liability Litigation. The hearing was just on September 24—a seven day turnaround time and a great victory for Plaintiffs.
The effect of the order is to transfer all YAZ and Yasmin drug defect cases that are now or later filed in federal courts to the United States District Court for the Southern District of Illinois. The judge in charge of coordinated and/or consolidated proceedings there will be Chief Judge David R. Herndon (a Clinton appointee who, while in private practice, primarily represented plaintiffs in FELA railroad cases).
This is a terrific and exciting move for the YAZ and Yasmin litigation. The MDL will enable attorneys to spend more time working on the common discovery in all of their cases, and less time on case management orders and case-specific motions practice. Consolidation will truly promote judicial efficiency, and will probably lead to a better result for all concerned.
For more on the YAZ, Yasmin and Ocella injuries and lawsuits, see other posts of the DrugRecallLawyerBlog.